Hyeok Choi

Hyeok Choi

Auto-generated profile, based on publicly available information

Hyeok Choi

Department of Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 August 2018 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
HCHyeok Choi
Hyeok Choi
YKYouhyun Kim
Youhyun Kim
SJSeung Min Jung
Seung Min Jung
JSJason Jungsik Song
Jason Jungsik Song
YPYong-Beom Park
Yong-Beom Park
SLSang-Won Lee
Sang-Won Lee

17 July 2017 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
HCHyeok Choi
Hyeok Choi
SYSeong-Yoon Yang
Seong-Yoon Yang
HCHee-Seung Cho
Hee-Seung Cho
WKWoorim Kim
Woorim Kim
Eun-Cheol ParkEun-Cheol Park
Eun-Cheol Park
KHKyu-Tae Han
Kyu-Tae Han
Many studies have assessed the volume-outcome relationship in cancer patients, but most focused on better outcomes in higher volume groups rather than identifying a specific threshold that could assist in clinical decision-making for achieving the best outcomes. The current study suggests an optimal volume for achieving good outcome, as an extension of previous studies on the volume-outcome relationship in stomach cancer patients. We used National Health Insurance Service (NHIS) Sampling Cohort data during 2004–2013, comprising healthcare claims for 2550 patients with newly diagnosed stomach cancer. We conducted survival analyses adopting the Cox proportional hazard model to investigate the association of three threshold values for surgical volume of stomach cancer patients for cancer-specific mortality using the Youden index. Overall, 17.10% of patients died due to cancer during the study period. The risk of mortality among patients who received surgical treatment gradually decreased with increasing surgical volume at the hospital, while the risk of mortality increased again in “high” surgical volume hospitals, resulting in a j-shaped curve (mid-low = hazard ratio (HR) 0.773, 95% confidence interval (CI) 0.608–0.983; mid-high = HR 0.541, 95% CI 0.372–0.788; high = HR 0.659, 95% CI 0.473–0.917; ref = low). These associations were especially significant in regions with unsubstantial surgical volumes and less severe cases. The optimal surgical volume threshold was about 727.3 surgical cases for stomach cancer per hospital over the 1-year study period in South Korea. However, such positive effects decreased after exceeding a certain volume of surgeries.

22 August 2019 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
MKMinyoung Kevin Kim
Minyoung Kevin Kim
HCHyeok Choi
Hyeok Choi
JKJae Yeon Kim
Jae Yeon Kim
JSJason Jungsik Song
Jason Jungsik Song
YPYong-Beom Park
Yong-Beom Park
SLSang-Won Lee
Sang-Won Lee
Background: So far, there has been no tool to estimate activity at diagnosis and predict all‐cause mortality in patients with ANCA‐associated vasculitis (AAV). Hence, we determined the initial predictors of them in patients with AAV. Methods: We retrospectively reviewed the medical records of 182 patients with AAV. Severe AAV was defined as Birmingham Vasculitis Activity Score (BVAS) ≥ 16. The cutoffs were extrapolated by the receiver operator characteristic (ROC) curve. The odds ratio (OR) and the relative risk (RR) were assessed using the multivariable logistic regression analysis and the chi‐square test, respectively. Results: In the comparison analysis, patients with severe AAV exhibited the higher neutrophil and platelet counts, creatinine, erythrocyte sedimentation rate and C‐reactive protein, and the lower lymphocyte count, hemoglobin, and serum albumin than those without. In the multivariable logistic regression analysis, creatinine ≥ 0.9 mg/dL (OR 2.264), lymphocyte count ≤ 1430.0/mm 3 (OR 1.856), and hemoglobin ≤ 10.8 g/dL (OR 2.085) were associated with severe AAV. We developed a new equation of a multivariable index for AAV (MVIA) = 0.6 × (Lymphocyte count ≤ 1430.0/mm 3 ) + 0.7 × (Hemoglobin ≤ 10.8 g/dL) + 0.8 × (Creatinine ≥ 0.9 mg/dL). The optimal cutoff of MVIA for severe AAV was set as 1.35. Severe AAV was identified more frequently in patients with MVIA at diagnosis ≥1.35 than those without (RR 4.432). Patients with MVIA at diagnosis ≥1.35 exhibited the lower cumulative patient survival rate than those without. Conclusion: Multivariable index for AAV could assess the cross‐sectional activity and predict all‐cause mortality in patients with AAV.

27 April 2021 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
HCHyeok Choi
Hyeok Choi
YPYong-Beom Park
Yong-Beom Park
JSJaewoo Song
Jaewoo Song
SLSang-Won Lee
Sang-Won Lee

12 November 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SLSoo Bin Lee
Soo Bin Lee
HCHyeok Choi
Hyeok Choi
MKMinyoung Kevin Kim
Minyoung Kevin Kim
SJSeung Min Jung
Seung Min Jung
JSJason Jungsik Song
Jason Jungsik Song
SLSang-Won Lee
Sang-Won Lee